Drug Trial Radar · NCT07476963
Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Mar 15, 2026
Primary completion
Jul 6, 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Forward Pharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Phase I, Single-Center, Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Effect of High-Fat and Low-Fat Meals on the Pharmacokinetics of FWD1802 in Chinese Healthy Subjects. The primary objectives are to address the following questions: To evaluate the impact of high-fat and low-fat meals on the pharmacokinetic (PK) characteristics of a single oral dose of FWD1802 in healthy Chinese Subjects.
Conditions
- Healthy
Interventions
FWD1802Drug
Single-dose of 150 mg of FWD1802.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Peak Plasma Concentration (Cmax)Time frame: 240 hours
- Area under the plasma concentration versus time curve (AUC0-t)Time frame: 240 hours
- Area under the plasma concentration versus time curve (AUC0-∞)Time frame: 240 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.